Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations
Authors:
- 5 June 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 5 (6) , 681-692
Abstract
Background: The design of a proper region-specific oral drug delivery system has to take into consideration the differences in anatomy, physiology and absorption characteristics that exist between segments within the gastrointestinal (GI) tract, as well as transit kinetics of the dosage form and the site of drug release within the GI tract. Objective: The aim of this review is to examine the various biopharmaceutical aspects of region-specific drug delivery in the GI tract. Methods: This review is mainly focused on pharmacokinetic and pharmacodynamic aspects of region-selective drug delivery with special emphasis on drug absorption pathways (para- and transcellular, absorption and efflux transporters, lymphatic uptake etc.). It includes a discussion of gastroretentive systems, colonic delivery, and lipid-based formulations. The review also addresses targeted therapy of local diseases within the GI tract. Conclusions: The advances in pharmaceutical technology allow for the development of a variety of regio...Keywords
This publication has 116 references indexed in Scilit:
- Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pyloriJournal of Controlled Release, 2008
- Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochlorideAAPS PharmSciTech, 2007
- Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humansJournal of Controlled Release, 2006
- Pharmacokinetics and Pharmacodynamics of a Novel Extended‐Release Ciprofloxacin in Healthy VolunteersThe Journal of Clinical Pharmacology, 2005
- Preparation and Evaluation of Floating Risedronate Sodium–Gelucire® 43/01 FormulationsDrug Development and Industrial Pharmacy, 2005
- XP13512 [(±)-1-([(α-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: II. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared with Gabapentin in Rats and MonkeysThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Stomach-Specific Anti-H. pyloriTherapy. II. Gastric Residence Studies of Tetracycline-Loaded Chitosan Microspheres in GerbilsPharmaceutical Development and Technology, 2003
- Statistical optimization of gastric floating system for oral controlled delivery of calciumAAPS PharmSciTech, 2001
- Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the RatJournal of Pharmaceutical Sciences, 1998
- Gastric diffusion of antibiotics used against Helicobacter pyloriInternational Journal of Antimicrobial Agents, 1998